Talecris Biotherapeutics can trace its origins back to the earliest efforts in the development of biological products — therapeutics derived from human plasma, the liquid portion of the blood.
Plasma contains many different therapeutic proteins, including protective antibodies, albumin and coagulation factors. These proteins are extracted from the plasma, purified, and used to manage serious and often life-threatening conditions such as lung disease caused by congenital alpha-1 antitrypsin deficiency; hemophilia, or other coagulation disorders; infection; shock; blood loss due to trauma, burns, and surgery; immune disorders; hepatitis, tetanus or rabies exposure.
The immunologic products described below are made from human plasma. Products made from human plasma may contain infectious agents, such as viruses, that can cause disease. The risk that such products will transmit an infectious agent has been reduced by screening plasma donors for prior exposure to certain viruses, by testing for the presence of certain current virus infections, and by inactivating and/or removing certain viruses. Despite these measures, such products can still potentially transmit disease. There is also the possibility that unknown infectious agents may be present in such products.
| Human Serum Products |
| Animal Serum Products |
| Human Based Components |
| Animal Based Components |
| Cell Culture Reagents |
| Recombinant Products |
